EX-FILING FEES 4 trvi-exfilingfees_45.htm EX-FILING FEES trvi-exfilingfees_45.htm

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Trevi Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Table 1 – Newly Registered Securities

 

Security Type

 

Security

Class

Title 

 

Fee

Calculation

Rule

 

Amount

Registered(1)

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price

 

Fee

Rate

 

Amount of

Registration

Fee

Equity

Common Stock, $0.001 par value per share 

Other (2)

1,425,290 (3)

$2.73 (2)

$3,891,041.70

.0000927

$360.70

Total Offering Amounts

$3,891,041.70

$360.70

Total Fee Offsets

Net Fee Due 

$360.70

 

(1)

Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of the Registrant’s common stock, $0.001 par value per share (“Common Stock”), that may from time to time be offered or issued to prevent dilution by reason of any stock dividend, stock split or other similar transaction.

(2)

The proposed maximum offering price per unit of $2.73 is estimated pursuant to Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee, and is based upon the average of the high and low prices of the Common Stock on April 29, 2022, as reported on the Nasdaq Global Market.

(3)

Consists of (i) 1,140,232 additional shares issuable under the Trevi Therapeutics, Inc. 2019 Stock Incentive Plan, and (ii) 285,058 additional shares issuable under the Trevi Therapeutics, Inc. 2019 Employee Stock Purchase Plan.